... Incidence %/mo ( 95% CI)% 0–30 Days14,609 58 9 198 1.4 (1.2–1.6) 1.4>1–6 Mo 13,997 767 340 0 .50 (0. 45 0 .55 ) 2 .5 >6–12 Mo 13, 157 50 9 211 0.27 (0.23–0.31) 1.6>1–2 Yr 12,622 754 240 0.18 ... Society for Heart and Lung Transplantation: twenty-second of-ficial adult heart transplant report — 20 05. J Heart Lung Transplant 20 05; 24:94 5- 5 5. Bader FM, Kfoury AG, Gilbert EM, et al. Percutaneous ... 20 05; 1 65: 206 9-7 6.Laufs U, Custodis F, Bohm M. HMG-CoA reductase inhibi-4. 5. 6.7.8.9.10.tors in chronic heart failure: potential mechanisms of benefit and risk. Drugs 2006;66:14 5- 5 4.Shepherd...